Novo Nordisk’s ousting of longtime CEO Lars Fruergaard Jørgensen bemused analysts, with many questioning the future of the Wegovy obesity drug maker.
Related Posts
Used vehicle prices expected to continue to stabilize in 2025 after pandemic volatility
Cox Automotive expects wholesale prices on its Manheim Used Vehicle Value Index will end this year 1.4% higher than in December 2024.
OpenAI says Robinhood’s tokens aren’t equity in the company
OpenAI said it was not involved in Robinhood’s launch of tokenized shares in Europe, warning users the assets were issued without its approval.
Will 2025 finally mark the end of the IPO drought?
Nasdaq president Nelson Griggs discusses the decline of companies going public and when the incentive for initial public offerings will return.